retatrutide chills 30 Days of — LessWrong Everything r/Retatrutide actually says about

Disclosures Anahi Perlas performs consulting work for Fujifilm Sonosite and receives peer-reviewed funding from the SHS-UHN Innovation Fund Award and a Womens College Hospital Innovation Fund Award (both, Toronto, ON, Canada)

Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below: As a result, the resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline

It is about maintaining capability and resilience as the body changes

Heres a breakdown of every major injectable peptide used for fat loss and how it stacks up

F., Sattar, N., Preiss, D., Kber, L., Petrie, M